521 related articles for article (PubMed ID: 25066321)
21. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
Littleton J; Zieglgänsberger W
Am J Addict; 2003; 12(s1):s3-s11. PubMed ID: 14972776
[TBL] [Abstract][Full Text] [Related]
23. [Neurobiological mechanisms and pharmacological treatment options for alcohol craving].
Hillemacher T; Kornhuber J; Bleich S
Fortschr Neurol Psychiatr; 2007 Jan; 75(1):26-32. PubMed ID: 17031777
[TBL] [Abstract][Full Text] [Related]
24. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
Petrov I; Krogh J; Nordentoft M
Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
[TBL] [Abstract][Full Text] [Related]
25. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
[TBL] [Abstract][Full Text] [Related]
26. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
Soyka M; Chick J
Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
[TBL] [Abstract][Full Text] [Related]
27. Recent developments in the pharmacotherapy of alcohol dependence.
Schuckit MA
J Consult Clin Psychol; 1996 Aug; 64(4):669-76. PubMed ID: 8803356
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
Kenna GA; McGeary JE; Swift RM
Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
[TBL] [Abstract][Full Text] [Related]
29. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
30. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacotherapy of alcohol withdrawal: update and new developments].
Soyka M; Rösner S
Nervenarzt; 2021 Jan; 92(1):57-65. PubMed ID: 32696076
[TBL] [Abstract][Full Text] [Related]
33. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
Mason BJ
J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
[TBL] [Abstract][Full Text] [Related]
34. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
35. Current pharmacotherapies of alcoholism: a U.S. perspective.
Anton RF; Swift RM
Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
[TBL] [Abstract][Full Text] [Related]
36. Trajectory analyses in alcohol treatment research.
Chen J; Johnson BA; Wang XQ; O'Quigley J; Isaac M; Zhang D; Liu L
Alcohol Clin Exp Res; 2012 Aug; 36(8):1442-8. PubMed ID: 22525000
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
Kranzler HR; Van Kirk J
Alcohol Clin Exp Res; 2001 Sep; 25(9):1335-41. PubMed ID: 11584154
[TBL] [Abstract][Full Text] [Related]
38. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
Roos CR; Mann K; Witkiewitz K
Addict Biol; 2017 Nov; 22(6):1528-1539. PubMed ID: 27480445
[TBL] [Abstract][Full Text] [Related]
39. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
Kim SG; Han BD; Park JM; Kim MJ; Stromberg MF
Psychiatry Clin Neurosci; 2004 Feb; 58(1):30-6. PubMed ID: 14678454
[TBL] [Abstract][Full Text] [Related]
40. Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
